Abbott EVP sells 263 shares in insider Form 4

Abbott Laboratories executive Elizabeth C. Cushman reported two share dispositions.

Rhea-AI Filing Summary

Abbott Laboratories executive Elizabeth C. Cushman reported two share dispositions. On March 2, she completed an open-market sale of 263 common shares at $115.58 per share, leaving her with 38,573 shares held directly.

On February 27, she disposed of 1,421 shares at $116.26 per share to cover tax obligations through a tax-withholding transaction, rather than a traditional sale. Both transactions involve Abbott common shares without par value and reflect routine insider activity by the company’s EVP, General Counsel and Secretary.

Insider Trade Summary

Net Seller: 263 shares

Net Sell 2 txns

Insider Cushman Elizabeth C.

Role EVP, GC AND SECRETARY

Sold 263 shs ($30K)

Type	Security	Shares	Price	Value
Sale	Common shares without par value	263	$115.58	$30K
Exercise Price or Tax Liability	Common shares without par value	1,421	$116.26	$165K

Holdings After Transaction: Common shares without par value — 38,573 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Abbott (ABT) executive Elizabeth C. Cushman report?

Elizabeth C. Cushman reported two dispositions of Abbott common shares. She sold 263 shares in an open-market transaction and disposed of 1,421 shares to satisfy tax withholding obligations, both involving common shares without par value on late February and early March 2026.

How many Abbott (ABT) shares did Elizabeth C. Cushman sell on the open market?

Elizabeth C. Cushman sold 263 Abbott common shares in an open-market transaction. The sale occurred on March 2, 2026, at a price of $115.58 per share, as part of her directly held position as EVP, General Counsel and Secretary of Abbott Laboratories.

At what prices were Elizabeth C. Cushman’s Abbott (ABT) share transactions executed?

Her open-market sale of 263 Abbott common shares executed at $115.58 per share. A separate tax-withholding disposition of 1,421 shares occurred at $116.26 per share, reflecting delivery of shares to cover tax liabilities rather than traditional market selling activity.

How many Abbott (ABT) shares does Elizabeth C. Cushman hold after these transactions?

Following the March 2, 2026 open-market sale, Elizabeth C. Cushman directly holds 38,573 Abbott common shares. This post-transaction balance reflects her remaining ownership after disposing of 263 shares in the market and 1,421 shares for tax-withholding purposes in late February 2026.

Was any part of Elizabeth C. Cushman’s Abbott (ABT) Form 4 activity for tax withholding?

Yes, 1,421 Abbott common shares were disposed of to satisfy tax obligations. This transaction, coded “F,” represents payment of tax liability by delivering securities, distinct from her separate open-market sale of 263 shares reported in the same Form 4 filing.

What role does Elizabeth C. Cushman hold at Abbott (ABT) in relation to this Form 4?

Elizabeth C. Cushman serves as Abbott’s Executive Vice President, General Counsel and Secretary. Her Form 4 filing reflects changes in her directly held common shares, including an open-market sale and a tax-withholding disposition, both involving Abbott common shares without par value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 07:39 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cushman Elizabeth C.

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK IL 60064

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, GC AND SECRETARY

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common shares without par value	02/27/2026		F		1,421	D	$116.26	38,836	D
Common shares without par value	03/02/2026		S		263	D	$115.58	38,573	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Elizabeth C. Cushman by Jessica H. Paik, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.